March 2013

Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

Condition:   Leukemia
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Alloreactive NK infusion;   Drug: Interleukin-2;   Procedure: Stem Cell Infusion;   Drug: G-CSF;   Drug: Tacrolimus;   Drug: Methotrexate
Sponsors:   M.D. Anderson Cancer Center;   Cancer Prevention Research Institute of Texas;   CML Program Project Grant
Recruiting - verified September 2016

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Conditions:   Refractory Non Hodgkin Lymphoma;   Relapsed Non Hodgkin Lymphoma
Interventions:   Biological: rituximab;   Biological: ibritumomab tiuxetan;   Biological: anti-thymocyte globulin;   Radiation: total nodal irradiation;   Procedure: peripheral blood stem cell transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil
Sponsors:   University of California, Davis;   Spectrum Pharmaceuticals, Inc
Recruiting - verified June 2016

Mexiletine for the Treatment of Muscle Cramps in ALS

Condition:   Muscle Cramps in Amyotrophic Lateral Sclerosis
Interventions:   Drug: Mexiletine;   Drug: Placebo
Sponsors:   Bjorn Oskarsson, MD;   University of California, Davis;   ALS Association
Completed - verified May 2016

Clinical Trial Nuedexta in Subjects With ALS

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Interventions:   Drug: Nuedexta;   Drug: Matching Placebo
Sponsors:   Center for Neurologic Study, La Jolla, California,;   ALS Association;   State University of New York - Upstate Medical University
Completed - verified June 2016